Podcasts about MIPS

Go check out our FREE Skool community, it's got amazing tools in there and a thriving community of cyclists - https://www.skool.com/roadman/aboutToday, Anthony sits down with rock 'n' roll musician Ostella.She's played sold-out shows across Ireland and Canada, but what really sets her apart is how she gets there: Ostella has bikepacked to her gigs, carrying her guitar and equipment on the road with a zero-carbon footprint.She even brought her guitar into the studio and treated us to a few of her incredible songs live.One of the tools you will have heard Anthony chat about in this podcast is Training Peaks. Without this platform we can't get into the detail required to pricesly train within zones. If you want to go and check out this incredible training tool go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bit.ly/4qWyEKK⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and use ROADMAN – 20% off an annual TrainingPeaks Premium subscription⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Parlee Cycles ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠"Whether it's a tough day, a gruelling training session, an epic road trip or sitting on the side of the road, exhausted and wondering how you'll get to the top... The answer is regularly to just get back in the saddle and ride. Ride The F...ing Bike. RTFB!"Go check out their amazing bikes at https://www.parleecycles.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠4Endurance⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Pro level fuel, made accessible. Myself and Sarah trust 4Endurance for all our fuelling needs. Their reange is HUGE and won't break the bank. Go check them out here https://4endurance.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠BIKMO⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Bikmo protects you and your bike fromtheft, accidental damage, race-day disasters, and even baggage claim shenanigans. Yourhelmet, GPS, and other kit are covered too. Got more than one bike? Of course you do – you get 50% off each extra bike on the same policy.Protect your ride before it's too late – head to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Bikmo.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to get covered. ⁠⁠⁠POC ⁠⁠⁠POC's new Amidal brings aero performance, cooling, and safety together, with Mips protection, deep ventilation, and a cleanly integrated rear Knog light.Head to ⁠⁠⁠poc.com⁠⁠⁠ to check out the Amidal and see why it could become your go-to helmet for every ride.⁠⁠⁠VITTORIA TYRES⁠⁠⁠Make choosing your next gravel tyre simple with Vittoria's terrain-based range, from fast-rolling options to grippier tyres for rougher rides.Head to Vittoria.com to find the tyre that matches the terrain you actually ride.

Imagine being penalized for delivering good care to your frailest patients. Medicare's quality scoring program was built for healthy outpatients, not the elderly residents of nursing homes, but it is the system doctors who round in skilled nursing facilities are forced to play. Steve Buslovich, a physician executive and geriatrician, discusses the KevinMD article "How Medicare's MIPS impacts skilled nursing facilities and clinicians." You'll hear how MIPS metrics conflict with the five-star quality measures facilities must report, why tightly controlling A1C in frail elders can cause harm, and how documentation discrepancies between physicians and facilities create financial and legal risk for both. You'll learn which nine measures actually fit post-acute long-term care, why CMS needs frailty-based quality metrics, and how AI and synced EHRs can pull data automatically so clinicians can get back to the bedside. If you practice in or operate a nursing home, this conversation names the rules of a game you didn't choose to play. Partner with me on the KevinMD platform. With over three million monthly readers and half a million social media followers, I give you direct access to the doctors and patients who matter most. Whether you need a sponsored article, email campaign, video interview, or a spot right here on the podcast, I offer the trusted space your brand deserves to be heard. Let's work together to tell your story. PARTNER WITH KEVINMD → https://kevinmd.com/influencer SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

Go check out our FREE Skool community, it's got amazing tools in there and a thriving community of cyclists - https://www.skool.com/roadman/aboutThe Tour de France wasn't born from pure sporting ambition. It began with a political scandal, a newspaper war, and a desperate attempt to sell more papers. In 1890s France, the Dreyfus Affair split the country in two, dragging even the cycling press into the fight. When powerful industrialists turned against pro-Dreyfus editor Pierre Giffard and his paper Le Vélo, they funded a rival: L'Auto. Struggling to survive, L'Auto launched a brutal race around France in 1903. That publicity stunt became the Tour de France — and even gave cycling its famous yellow jersey.One of the tools you will have heard Anthony chat about in this podcast is Training Peaks. Without this platform we can't get into the detail required to pricesly train within zones. If you want to go and check out this incredible training tool go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bit.ly/4qWyEKK⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and use ROADMAN – 20% off an annual TrainingPeaks Premium subscription⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Parlee Cycles ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠"Whether it's a tough day, a gruelling training session, an epic road trip or sitting on the side of the road, exhausted and wondering how you'll get to the top... The answer is regularly to just get back in the saddle and ride. Ride The F...ing Bike. RTFB!"Go check out their amazing bikes at https://www.parleecycles.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠4Endurance⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Pro level fuel, made accessible. Myself and Sarah trust 4Endurance for all our fuelling needs. Their reange is HUGE and won't break the bank. Go check them out here https://4endurance.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠BIKMO⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Bikmo protects you and your bike fromtheft, accidental damage, race-day disasters, and even baggage claim shenanigans. Yourhelmet, GPS, and other kit are covered too. Got more than one bike? Of course you do – you get 50% off each extra bike on the same policy.Protect your ride before it's too late – head to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Bikmo.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to get covered. ⁠⁠POC ⁠⁠POC's new Amidal brings aero performance, cooling, and safety together, with Mips protection, deep ventilation, and a cleanly integrated rear Knog light.Head to ⁠⁠poc.com⁠⁠ to check out the Amidal and see why it could become your go-to helmet for every ride.⁠⁠VITTORIA TYRES⁠⁠Make choosing your next gravel tyre simple with Vittoria's terrain-based range, from fast-rolling options to grippier tyres for rougher rides.Head to Vittoria.com to find the tyre that matches the terrain you actually ride.

Go check out our FREE Skool community, it's got amazing tools in there and a thriving community of cyclists - https://www.skool.com/roadman/aboutIs aerodynamics only for pros, time triallists, and triathletes — or should everyday cyclists care too? In this episode, we cut through the hype and ask whether aero is genuinely “free speed” or just expensive cycling nonsense. We explain why the rider creates most of the drag, why body position and clothing often matter more than pricey upgrades, and when aero does — and does not — make a real difference. From £0 changes like zipping up your jersey and tucking your elbows, to smarter kit choices, this episode helps average cyclists save energy, ride faster, and avoid wasting money.One of the tools you will have heard Anthony chat about in this podcast is Training Peaks. Without this platform we can't get into the detail required to pricesly train within zones. If you want to go and check out this incredible training tool go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bit.ly/4qWyEKK⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and use ROADMAN – 20% off an annual TrainingPeaks Premium subscription⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Parlee Cycles ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠"Whether it's a tough day, a gruelling training session, an epic road trip or sitting on the side of the road, exhausted and wondering how you'll get to the top... The answer is regularly to just get back in the saddle and ride. Ride The F...ing Bike. RTFB!"Go check out their amazing bikes at https://www.parleecycles.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠4Endurance⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Pro level fuel, made accessible. Myself and Sarah trust 4Endurance for all our fuelling needs. Their reange is HUGE and won't break the bank. Go check them out here https://4endurance.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠BIKMO⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Bikmo protects you and your bike fromtheft, accidental damage, race-day disasters, and even baggage claim shenanigans. Yourhelmet, GPS, and other kit are covered too. Got more than one bike? Of course you do – you get 50% off each extra bike on the same policy.Protect your ride before it's too late – head to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Bikmo.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to get covered. ⁠POC ⁠POC's new Amidal brings aero performance, cooling, and safety together, with Mips protection, deep ventilation, and a cleanly integrated rear Knog light.Head to ⁠poc.com⁠ to check out the Amidal and see why it could become your go-to helmet for every ride.⁠VITTORIA TYRES⁠Make choosing your next gravel tyre simple with Vittoria's terrain-based range, from fast-rolling options to grippier tyres for rougher rides.Head to Vittoria.com to find the tyre that matches the terrain you actually ride.

Go check out our FREE Skool community, it's got amazing tools in there and a thriving community of cyclists - https://www.skool.com/roadman/aboutCycling was never meant to be about looking expensive. The real entry ticket was willingness: to learn, to listen, to hold a wheel without panic, to respect the rhythm of the group. Somewhere along the way, the gate shifted. Skill started getting confused with image. Kit became a costume. Beginners began feeling like they had to buy belonging before they'd earned confidence on the road. But the magic of cycling has always lived somewhere else: in trust, timing, craft, and the quiet romance of a bunch rolling out together. The question is, are we protecting that—or pricing people out of it?One of the tools you will have heard Anthony chat about in this podcast is Training Peaks. Without this platform we can't get into the detail required to pricesly train within zones. If you want to go and check out this incredible training tool go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bit.ly/4qWyEKK⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and use ROADMAN – 20% off an annual TrainingPeaks Premium subscription⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Parlee Cycles ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠"Whether it's a tough day, a gruelling training session, an epic road trip or sitting on the side of the road, exhausted and wondering how you'll get to the top... The answer is regularly to just get back in the saddle and ride. Ride The F...ing Bike. RTFB!"Go check out their amazing bikes at https://www.parleecycles.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠4Endurance⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Pro level fuel, made accessible. Myself and Sarah trust 4Endurance for all our fuelling needs. Their reange is HUGE and won't break the bank. Go check them out here https://4endurance.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠BIKMO⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Bikmo protects you and your bike fromtheft, accidental damage, race-day disasters, and even baggage claim shenanigans. Yourhelmet, GPS, and other kit are covered too. Got more than one bike? Of course you do – you get 50% off each extra bike on the same policy.Protect your ride before it's too late – head to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Bikmo.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to get covered. ⁠POC ⁠POC's new Amidal brings aero performance, cooling, and safety together, with Mips protection, deep ventilation, and a cleanly integrated rear Knog light.Head to ⁠poc.com⁠ to check out the Amidal and see why it could become your go-to helmet for every ride.⁠VITTORIA TYRES⁠Make choosing your next gravel tyre simple with Vittoria's terrain-based range, from fast-rolling options to grippier tyres for rougher rides.Head to Vittoria.com to find the tyre that matches the terrain you actually ride.

Go check out our FREE Skool community, it's got amazing tools in there and a thriving community of cyclists - https://www.skool.com/roadman/aboutDuring Nazi-occupied Italy, cycling legend Gino Bartali used the one thing that made him untouchable—his fame—to help save Jewish lives. Disguised as training rides, his journeys carried forged identity papers hidden inside his bicycle frame, past checkpoints where soldiers asked for autographs instead of searches. This episode uncovers how Bartali, already a Tour de France champion, risked prison, torture, and execution as part of a secret rescue network spanning Florence and Assisi. Yet for decades, he told almost no one. A story of courage, faith, silence, and the extraordinary power of doing good without needing to be seen.One of the tools you will have heard Anthony chat about in this podcast is Training Peaks. Without this platform we can't get into the detail required to pricesly train within zones. If you want to go and check out this incredible training tool go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bit.ly/4qWyEKK⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and use ROADMAN – 20% off an annual TrainingPeaks Premium subscription⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Parlee Cycles ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠"Whether it's a tough day, a gruelling training session, an epic road trip or sitting on the side of the road, exhausted and wondering how you'll get to the top... The answer is regularly to just get back in the saddle and ride. Ride The F...ing Bike. RTFB!"Go check out their amazing bikes at https://www.parleecycles.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠4Endurance⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Pro level fuel, made accessible. Myself and Sarah trust 4Endurance for all our fuelling needs. Their reange is HUGE and won't break the bank. Go check them out here https://4endurance.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠BIKMO⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Bikmo protects you and your bike fromtheft, accidental damage, race-day disasters, and even baggage claim shenanigans. Yourhelmet, GPS, and other kit are covered too. Got more than one bike? Of course you do – you get 50% off each extra bike on the same policy.Protect your ride before it's too late – head to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Bikmo.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to get covered. POC POC's new Amidal brings aero performance, cooling, and safety together, with Mips protection, deep ventilation, and a cleanly integrated rear Knog light.Head to poc.com to check out the Amidal and see why it could become your go-to helmet for every ride.VITTORIA TYRESMake choosing your next gravel tyre simple with Vittoria's terrain-based range, from fast-rolling options to grippier tyres for rougher rides.Head to Vittoria.com to find the tyre that matches the terrain you actually ride.

In the spirit of recording content at Conferences, we want to replay a special episode with Ryan Walsh, Chief Strategy Officer, Pax8. Enjoy and be in the look out for exciting episodes from Beyond 26. Success doesn't happen by accident—it's a journey we must own, and that begins with the right mindset. Ryan Walsh, Co-founder and Chief Strategy Officer at Pax8 discusses the power of strategic leadership, embracing innovation, and the importance of cultivating community within the channel. From his rock-climbing analogy of navigating challenges to his passion for helping MSPs grow through “guided growth” and “amplifying uniqueness,” Ryan underscores the need for focused vision and teamwork.   Highlights also include: A glimpse into the Voyager Alliance partner program. The expanding influence of AI, agents, and a shift to managed intelligence partners (MIPs). To be competitive means owning a niche, staying connected, and thinking collaboratively. Family and basketball as foundational to his leadership philosophy.   His leadership philosophy, rooted in enabling others and fostering shared success, offers valuable lessons for anyone seeking to lead with purpose in a rapidly changing tech landscape. Follow Ryan on LinkedIn and visit Pax8.com to stay informed about the marketplace.   Timestamps: [08:21] Father modeled passion [18:03] Voyager Alliance Growth Tracks [18:57] Owning your niche [23:05] Power of Team   --- more ---   If you want to master the art of audience engagement while learning how to conquer speaking anxiety, deliver persuasive presentations, and close more deals, this is the program for you. Twins Talk It Up is hosted by identical twin brothers Danny Suk Brown and David Suk Brown, who share leadership communication strategies designed to help professionals embrace the power of their authentic voice.   Together, we'll explore tips and tools to unlock the full potential of your voice, dominate every stage you step onto, and elevate your influence and value. Along the way, we'll crush goals and share plenty of laughs.   Book a Free 15-minute discovery call: dsbleadershipgroup.com/schedule-a-call/ Website: appmeetup.com/twinstalkitup/ Community: facebook.com/groups/publicspeakingpoints Patreon: patreon.com/twinstalkitup

Salesforce made waves in February 2026 by introducing the Agentic Work Unit, or AWU, as a new way to measure and potentially price AI agent activity. The Metrics Brothers, Ray "Growth" Rike and Dave "CAC" Kellogg dig into whether the AWU is a legitimate step toward outcome-based pricing, a vendor-specific adoption metric, or just another awkward intermediate measure in the long, messy history of software pricing models.Episode Highlights:Tokens are not business metrics. Ray and Dave open by drawing a clear line: tokens measure text processing and compute consumption, not business outcomes. Nobody walks into a board meeting announcing they processed 14 billion word fragments, and enterprise buyers should not be priced on that basis.What Salesforce is actually trying to do with the AWU. Defined as "one discrete task accomplished by an AI agent," the AWU is Salesforce's attempt to bridge the gap between low-level compute metrics and business outcomes. The hosts debate whether it is a pricing metric in waiting, an AI adoption signal, or simply the best available approximation of work performed by agents.A short history of bad pricing units. From CPU counts to MIPS to kilocharacters to gigabytes, Ray and Dave trace the long, humbling history of software vendors searching for a pricing metric that maps to value. The Soviet chandelier analogy makes an appearance, courtesy of Appian CEO Matt Calkins.Activity versus outcome: the core tension. Ray argues the AWU is directionally right but fundamentally an activity metric, not a true economic outcome. Dave is more skeptical that outcome-based pricing can scale broadly, pointing out that customers say they want value-based pricing until a vendor actually tries to take a cut of the upside.Vertical AI applications have the clearest path. Both hosts agree that verticals with well-defined, countable outputs, such as cases resolved in customer support or claims processed in insurance, are best positioned to price on outcomes and may not need the AWU at all.The AWU needs a new name, and probably a new definition. Ray and Dave close with the observation that just as NRR took nearly a decade to emerge as a standard SaaS metric, meaningful AI metrics will take time to mature. The AWU, as currently defined, is a Salesforce-specific construct and unlikely to become an industry standard.If you are a B2B SaaS or AI-Native software operating executive, this conversation on one of the first agentic AI metrics to measure work activity is a great listen.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Is the Merit-based Incentive Payment System (MIPS) fulfilling its intended purpose, or is it just causing headaches? Dr. George Williams and Joe Reyes join host Dr. Andrew Pouw to share their expertise and experience with MIPS, including its evolultion from prior medical cost control policies and how ophthalmologists can use the IRIS Registry to meet reporting requirements.  For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts

An airhacks.fm conversation with Ian Rogers (@Ian Rogers) about: ZX Spectrum 128K with rubber keys and a burning side grill, Basic programming competitions, REM commands as ASCII art, PC versus Amiga and Archimedes era in the UK, fractal landscape generators for Wing Commander 4 cut scenes, Ocean Software in Manchester and the Head Over Heels game, Manchester Baby and Williams tube as the first stored-program computer, Steve Furber and ARM origins at the University of Manchester, Cosworth and Pi Research Formula One telemetry, transputers and embedded PowerPC data loggers, dynamic binary translation with the Dynamite simulator, ICL 2900 emulation for the Israeli tax system, MIPS to Itanium binary translation for SGI machines, Transitive Corporation and the PowerPC to x86 product that became Apple Rosetta, the Steve Jobs era at Apple, Spark to Power binary translation and the IBM acquisition of Transitive, JDBC versus ODBC API design observations, java.util.Vector and java.util.Hashtable synchronization decisions, StringBuilder array copying overhead from removing synchronization, DARPA HPCS languages Fortress, Chapel, X10, just-in-time parallelization from Java bytecode, LCC compiler from Princeton and the iBerg backend, JikesRVM as a metacircular Java VM written in Java, GNU Classpath and Sable VM by Etienne Gagnon, Apache Harmony port of JikesRVM to Windows, Maxwell and Maxine VMS as GraalVM precursors, Bernd Mathiske and the Sun acquisition by Oracle, GNU Classpath impact of the openJDK GPL release at FOSDEM 2006, Mark Wielaard and Rémi Forax FOSDEM stories, trace compilation and de-optimization parallels with JIT, Azul Systems Vega hardware and concurrent garbage collection, C4 collector design influencing ZGC and Shenandoah, Gil Tene's telephone exchange mentality for JVM responsiveness, page unmapping and signal handler memory pressure problems in HotSpot, Cliff Click and Modular, Google Android Runtime (ART) replacing Dalvik, transactional memory for class initializers in ART, ELF files and OAT format for ahead-of-time compilation, WhatsApp bytecode obfuscation breaking the ART verifier, lock balance verification for speculative lock optimizations, D8 and R8 Android compilers, Goit internal Google bytecode optimizer, Jeremy Manson and Google's OpenJDK variant, Linux kernel performance work and perf tooling, JikesRVM stack trace format making exception-heavy DaCapo benchmarks faster than HotSpot, Energy Efficiency across Programming Languages study comparing Java and Go, Ian Rogers on twitter: @Ian Rogers

Denna vecka blir det fullt ös med rapporter. Teckna-sälj i Silex? Hur stor är moderisken i Nelly? Är oreglerade slots lönsamt för Hacksaw? Har Niklas slagit i huvudet eller har han en Mips-hjälm? Detta, och mycket mer i dagens avsnitt! $CINT $AVT $ALBERT $HACK $NELLY $MIPS $MSON $TEQStort tack till vår huvudsponsor, Montrose! Besök https://www.montrose.io/ idag och använd koden “marketmakers” för att bli Premium-kund i tre månader!Tack också till Quanor! Testa marknadens bästa AI-verktyg du med på https://www.quanor.com/sv Med koden MM26 får du en månad gratis (för nya kunder)!Vi säger stort tack till Avionero!(Ungefärliga) Tidsstämplar:03:40 Silex Microsystems07:20 Cint Group $CINT13:20 AVTECH Sweden $AVT16:40 eEducation Albert $ALBERT20:55 Hacksaw $HACK25:30 Nelly Group $NELLY35:20 Mips $MIPS38:50 Midsona $MSON41:50 Teqnion $TEQ—Twitter: https://twitter.com/marketmakerspod Kontakt: podcast@marketmakers.se Hemsida: https://www.marketmakers.se/ Niklas, Fabian och Magnus finns förstås också på Twitter:https://twitter.com/alden_niklas https://twitter.com/franzen_fabian https://twitter.com/analytikern1234 Hosted on Acast. See acast.com/privacy for more information.

The Merit-based Incentive Payment System (MIPS) has become a high-stakes mandate that could determine the financial survival of modern practices and the physicians who care for long-term care residents. While the Centers for Medicare & Medicaid Services quality program has existed for years, a "perfect storm" of increasing penalties and a national push toward value-based care is forcing post-acute providers to better support active clinical participation — and to form more meaningful partnerships between SNF operators, PAC physician practices and value-based care model entities such as ISNPs, hospital-based ACOs and PAC-centric ACOs. "There's this sort of perfect storm of confusion happening between different CMS programs that a patient may be attributed to... that the practice now has to keep track of somehow," says Steve Buslovich, chief medical officer for senior care at PointClickCare. In the latest episode of the Market Leaders podcast, McKnight's Long-Term Care New Senior Editor Kimberly Marselas sits down with Buslovich and Tom Haithcoat, vice president of government affairs with Care Connect MD and president of Ceptor Consulting. Together, they decode how MIPS is influencing care — and coordination — at the bedside, as well as the friction between traditional primary care metrics and the unique realities of the geriatric population. They also explore why stronger alignment and collaboration across SNFs, physician groups and value-based entities is becoming essential to succeed under evolving CMS models. Penalties for non-compliance or poor reporting can now slash Medicare reimbursement by up to 9%, often representing the difference between a practice being "in the black or in the red,” Buslovich says. But often, Haithcoat adds, failure to capture care may be a reflection of missing or misaligned technology rather than lapses in patient treatments. Listen in to learn why practitioners often struggle to capture quality measures across fragmented systems, and how the MIPS measures themselves may be a mismatch for today's skilled nursing and senior living residents. If you need a full breakdown on helping reduce the burden for your community's physicians and clinicians as they navigate MIPS pathways, this is the episode for you. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

For years, the SRA measure under MIPS Promoting Interoperability was a single yes/no attestation. Did you conduct or review a Security Risk Analysis? Check. Done.Starting with the 2026 performance year, CMS added a second required attestation: did you conduct security risk management activities in accordance with the HIPAA Security Rule? A "no" on either attestation zeros out your entire PI score, which can significantly impact your MIPS performance and contribute to negative Medicare payment adjustments (up to 9% under MIPS overall).This episode breaks down what changed, why CMS is pushing beyond the checkbox, and what it means for practices that need to show they're not just completing an SRA but acting on the findings.Learn more about Medcurity here: https://medcurity.com#Healthcare #HIPAA #Cybersecurity #MIPS #SecurityRiskAnalysis #HealthcareIT #Compliance #HIPAACompliance #PromotingInteroperability #MedicareReimbursement

I veckans avsnitt kikar vi närmare på aktierna som gått bäst senaste veckan, några spännande nyheter från Montrose, hur miljonärerna agerat i mars månad och vad de nya bolånereglerna innebär. Dessutom djupdyker vi ned i skillnaderna mellan Mips, Thule och Dometic. Samtliga är sällanköpsbolag men med helt olika marginalprofil, vad beror det på?Glad påsk,Nicklas & VictorDe pengar som placeras kan både öka och minska i värde och det är inte säkert att du får tillbaka hela det insatta kapitalet. Historisk avkastning är ingen garanti för framtida avkastning. Hosted on Acast. See acast.com/privacy for more information.

Audible Bleeding editor Wen Kawaji (@WenKawaji) and 5th-year general surgery resident Sasank Kalipatnapu (@ksasank) from UMass Chan Medical School host SVS QPMC leadership Dr. Shutze, Dr. Hicks and Carrie McGraw to take a deep dive into the Vascular Surgery–specific Merit Based Incentive Payment System Value Pathway or MVP.   Show Guests    Dr. William Shutze: Associate Professor at Texas A&M College of Medicine at Texas A&M Health Science Center in Dallas Texas. He is a managing partner at Texas Vascular Associates. He is the co-chair for the SVS Vascular Center Verification and Quality Improvement program, vice chair for the SVS QPMC committee  Dr. Caitlin Hicks: Associate professor at Johns Hopkins University school of medicine, vice chair of research in the department of surgery. Chair for the SVS QPMC committee Carrie McGraw: SVS manager of Quality Improvement and Practice   Important resources 2026 Vascular MVP PDF: https://qpp-cm-prod-content.s3.amazonaws.com/uploads/3100/Vascular-Surgery-MVP-Candidate.pdf SVS Quality improvement contact email: SvsQuality@vascular.org Vascular Specialist article: https://vascularspecialistonline.com/introducing-the-vascular-surgery-mips-value-pathway-a-new-era-for-meaningful-specialty-driven-quality-reporting/ Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.   *Gore is a financial sponsor of this podcast, which has been independently developed by the presenters and does not constitute medical advice from Gore. Always consult the Instructions for Use (IFU) prior to using any medical device.  

How do we decide what “good care” looks like, and who gets to choose the scorecard? In this episode of Turn on the Lights, Kedar Mate speaks with Dr. Michelle Schreiber of the Centers for Medicare & Medicaid Services and Brenna Rabel of Battelle about how quality measures are developed, adopted, and applied across Medicare and Medicaid programs. They explore why measurement is essential for accountability, patient choice, and improvement, while also acknowledging its vulnerability to politics, feasibility constraints, and “teaching to the test.” Using diabetes and sepsis as examples, they explain how performance cutoffs are established, why “all-or-none” measures often face resistance, and what makes complex measures difficult to report and score. The conversation also addresses efforts to reduce reporting burden, including CMS's shift from broader MIPS reporting toward MIPS Value Pathways and the expansion of digital quality measurement through FHIR-enabled eCQMs. They conclude with a forward-looking discussion on how artificial intelligence could reduce manual chart abstraction and advance quality measurement, particularly as patient-reported outcomes play a larger role in shaping the future of value-based care. Tune in to hear how measures shape what health systems prioritize, what gets improved, and what “value” could look like in the future. Resources: Connect with and follow Dr. Michelle Schreiber on LinkedIn. Follow CMS on LinkedIn and explore their website! Connect with and follow Brenna Rabel on LinkedIn. Follow Battelle on LinkedIn and explore their website! Learn more about your ad choices. Visit megaphone.fm/adchoices

Review recent intracerebral hemorrhage (ICH) trials that have utilized minimally invasive surgical procedures (MIPS). Expert faculty will provide concise overviews of key studies including ENRICH, MIND, and MISTIE III highlighting critical findings and their implications for clinical practice. The session will also offer practical insights on navigating time-sensitive decision-making and prioritizing workflow to optimize patient outcomes.

Stark tillväxt från poddcastbolaget Acast och första ordinarie utdelningen från Storytel. Mips förväntas fortsätta tyngas av legala kostnader under hela 2026. Och så vill Nordic Capital göra sig av med aktier i Noba – trots att man då bryter mot inlåsningsavtal. Gäster i dagens program, Robin Gartner, mäklare Handelsbanken, Robert Andersson, analytiker DI. Programledare, Noel Hermansson och Fredrik Lennander.

This show has been flagged as Clean by the host. These are the commands mentioned in the You may need to use "sudo" to run these commands depending on how your system is configured. strace uptime strace ls 2>&1 | grep open strace -e openat ls / strace ls /does/not/exist strace -o ls-trace.log ls strace -ff -o pid12345-trace.log -p 12345 HISTORY The original strace was written by Paul Kranenburg for SunOS and was inspired by its trace utility. The SunOS version of strace was ported to Linux and enhanced by Branko Lankester, who also wrote the Linux kernel support. Even though Paul released strace 2.5 in 1992, Branko's work was based on Paul's strace 1.5 release from 1991. In 1993, Rick Sladkey took on the project. He merged strace 2.5 for SunOS with the second release of strace for Linux, added many features from SVR4's truss(1), and produced a ver‐ sion of strace that worked on both platforms. In 1994 Rick ported strace to SVR4 and Solaris and wrote the automatic configuration support. In 1995 he ported strace to Irix (and became tired of writing about himself in the third person). Beginning with 1996, strace was maintained by Wichert Akkerman. During his tenure, strace development migrated to CVS; ports to FreeBSD and many architectures on Linux (including ARM, IA-64, MIPS, PA-RISC, PowerPC, s390, SPARC) were introduced. In 2002, responsibility for strace maintenance was transferred to Roland McGrath. Since then, strace gained support for several new Linux architectures (AMD64, s390x, SuperH), bi- architecture support for some of them, and received numerous additions and improvements in system calls decoders on Linux; strace development migrated to Git during that period. Since 2009, strace has been actively maintained by Dmitry Levin. During this period, strace has gained support for the AArch64, ARC, AVR32, Blackfin, C-SKY, LoongArch, Meta, Nios II, OpenRISC 1000, RISC-V, Tile/TileGx, and Xtensa architectures. In 2012, unmaintained and apparently broken support for non-Linux operating systems was removed. Also, in 2012 strace gained support for path tracing and file descriptor path decoding. In 2014, support for stack trace printing was added. In 2016, system call tampering was implemented. For the additional information, please refer to the NEWS file and strace repository commit log. Links https://strace.io https://en.wikipedia.org/wiki/Strace https://www.man7.org/linux/man-pages/man1/strace.1.html Provide feedback on this episode.

In this episode of 1st Talk Compliance, Kevin Chmura is joined by Robyn Johns, as they discuss recent updates to their November live webinar, Compliance Cliffs: Navigating Telehealth Waivers and Reimbursement Changes. Learn how the policy landscape has shifted in recent months—especially around telehealth flexibilities, controlled substance prescribing, and the 2026 CMS payment rules.   Kevin Chmura Welcome to 1st Talk Compliance. I’m Kevin Chmura, CEO of Panacea Healthcare Solutions. Today we’re bringing you a timely update on our November live webinar, Compliance Cliffs: Navigating Telehealth Waivers and Reimbursement Changes. Since that webinar, several policy changes have moved quickly, especially in telehealth flexibilities. Controlled substance prescribing and 2026 CMS payment rules. Before we jump in, just a quick note. 1st Talk Compliance is brought to you by 1st Healthcare Compliance, a part of Panacea Healthcare Solutions. We help healthcare organizations strengthen their compliance programs with practical education tools and compliance management support. So teams can reduce risk, keep pace with regulatory change and operate with confidence. Now I’m pleased to welcome back Robyn Johns from Med USA. Robyn, thanks for coming back. Robyn Johns Thanks, Kevin. I’m happy to be here. Kevin Chmura  Great. So, let’s jump in. So, in November on the webinar, we spent a lot of time on what people were calling the telehealth cliff, which was creating a tremendous amount of uncertainty on whether flexibilities would expire. Can you catch us up on what the status is now? Robyn Johns  Yeah. The major update is that the spending package released on January 20th includes extensions of the telehealth flexibilities all the way through December 31st of 2027. Kevin Chmura So that’s a pretty meaningful runway. That’s great, but I guess doesn’t eliminate compliance obligations, but it is reducing near-term uncertainty which give everybody some time to standardize workflows. So, it’s in the news, but maybe you could tell. So, what’s in the spending package at a high level and what should healthcare leaders like us be paying attention to? Robyn Johns   Right. So, it was the one from the 20th was a $1.2 trillion spending package released by the House Appropriations Committee and it was just passed yesterday on the 22nd in two separate votes by the full House. So, those bills included the remaining six of the twelve appropriations necessary to avert a government shutdown. So that’s good news for everyone. If we can get them across the finish line, they funded many of the federal government agencies such as HHS, Labor, Defense, HUD, and also Homeland Security. That was a contentious one. That’s why they had to do two separate votes. It funds them through fiscal year 2026, which ends on September 30th of this year. Kevin Chmura  So, OK, so we have a funding package with multiple healthcare policy riders. Not, I guess not too surprising in today’s day and age. So, besides the telehealth through 2027, what else is included in there that compliance and operational leaders should know about? Robyn Johns   So the writers also include PBM reform and it extends hospital at home actually through 2030, which is another one that hit a lot of facilities hard with the government shutdown. It extends Medicare dependent hospital and low volume hospital programs, which is really beneficial for our rural providers and it delays the Medicaid disproportionate share cut again until fiscal year 2028. Notably, for a lot of people, it does not include an extension of the ACA subsidies, which were such a sticking point in the government shutdown last fall. Kevin Chmura  Yeah, that that that last point is operationally really important and coverage instability often turns into eligibility churn and puts real pair mix pressures on the you know same patients, different coverage, right.? And that’s just you know probably increases downstream compliance and documentation stress. Yeah that’s a that’s a tough one. So what’s the timing of congressional action now? Robyn Johns So with the House passing all of the bills, they now send the full appropriations package to the Senate. The Senate will take all of that up when they return from recess on Monday the 26th, and will hopefully pass them all ahead of the January 30th deadline. And hopefully without any significant changes which might require them to go back to the house because the house will be on recess next week. Kevin Chmura  Wow. So split schedule, it’s why we should keep ourselves in a monitoring posture. I guess we should always be monitoring, but things are moving pretty quickly right now and you sort of get into that world of what is expected is not what’s in effect. Which is always, always a tough place to operate, but hey, that’s healthcare, isn’t it? So, given the extension to 2027, in your opinion, what should compliance teams be doing now? Like what’s some practical next steps? Robyn Johns First, you’ll want to make sure that your internal policies and educational materials reflect what’s currently in effect. No major changes since most of those telehealth things were extended, but it’s always good to double check because lots of things change around the beginning of the year. Also validate your payer specific rules. Medicare policy direction is influential, but commercial payers and state laws differ. So, you got to make sure that you are matching up with those differences. And then third, we should we talk about strengthening your auditing of documentation, the modifiers, your place of service, medical necessity, all of those things that can vary depending on the payer and the specific situation of the patient. Kevin Chmura  Yeah, that that payer variation point is where a lot of organizations end up being exposed, I guess, right? Telehealth’s not really governed by one rule. You’ve got federal policy, state overlays, and then you have commercial policy updates really coming at you a number of different ways. So, I guess a good controls to maintain maybe a payer policy matrix and try to align it into your documentation and coding guidance. Probably a solid piece of advice. Robyn Johns   Absolutely. Kevin Chmura   Yeah. So, let’s move on to probably one of the highest risk areas that we covered in the webinar, and that’s controlled substance prescribing via telehealth. What’s the latest there? Robyn Johns   Good news there as well. At the end of the year, DEA and HHS extended the telehealth flexibilities for prescribing controlled substances through this year, December 31st of 2026. There are a few rules that can apply, but because they extended the flexibilities, it’s pretty much status quo until they change it again at the end of the year. Kevin Chmura   Cool, so that’s a critical compliance area because of the high risk profile and it that really includes some regulatory scrutiny and enforcement, not really just a reimbursement issue. Robyn Johns   Yes, it’s highly watched. Kevin Chmura   Yeah. And I guess as well, it should be. So given that, what control should organizations prioritize right now to reduce risk in that area? Robyn Johns  Definitely you’ll want to have clear prescribing policies, good documentation standards, and role-based training. Also, usually they want to include identity verification and required checks when they’re applicable, and consistent auditing to ensure that your process is followed, not just written down. This is another area where state regulations can vary, so you would want to make sure that you are compliant in every state where you see patients. Kevin Chmura   Yes and you’re the expert, not me. But I guess I’d add if you expand health to if you expand the telehealth quickly, take time now to ensure your governance is mature. And I’m thinking credentialing, supervision, documentation and audit trails always the basics that can help you pulled up under scrutiny. Robyn Johns   Definitely. When you expand quickly, sometimes you sacrifice certain things for speed. So, you have a minute now to go back now that you’re sure that those policies aren’t changing anytime soon to just go back and make sure that everything’s in place, all of those areas. Kevin Chmura  Yeah, I mean like any business runs better and with certainty, but at healthcare we rarely have that. So, great. So, moving on to the 2026 CMS updates that that we talked about a little bit. So, there’s been some changes in payment policy that are driving operational changes and it’s where those operational changes come in, where we introduce compliance risks if teams can’t keep pace and often they can’t. So, what are the 2026 physician fee schedule highlights? Robyn Johns   Yeah. So, we talked about these back in November and of course they went into place at the beginning of this year. So, a little bit of good news there with the conversion factor. It included the 2.5% increase that had been mandated by Congress. It also included a .75% increase for clinicians in advanced APMs or a .25% increase for clinicians who participate in MIPS or who are exempt. And then there was also a .49 budget neutrality increase. Kevin Chmura So, so the real impact varies by payer mix, site of service and quality of participation. What about RVU related changes? Robyn Johns   So that’s kind of the devil in the details there. It also implemented a -2.5% efficiency adjustment on certain non-time based services to the physician work RVU and there is also a + or -50% practice expense RVU adjustment for facility based services. So, it’s -50% if it’s facility based services or a +50% for non-facility based services. Kevin Chmura   Wow. So site of service is increasingly strategic and it’s where we see compliance issues often arise, right? You get inconsistent documentation, coding and policy adoptions across different departments and locations. Certainly not easy. Robyn Johns   No. Something you definitely need to watch closely because it is different depending on where you are and what services you’re providing. Kevin Chmura   Yeah. So, one other hotspot or another hotspot that that we often see is incident to. What's going on there? Robyn Johns  So the physician fee schedule in that they updated the definition of direct supervision for incident to billing to permanently allow supervision through real-time audio video communication except for services that have a 10 or a 90-day global surgery period. So, the supervising physician no longer has to be physically present in the office suite, they just have to be immediately available through real time audio video communication. Kevin Chmura   OK, so that’s operationally pretty significant, right? But I guess the compliance take away is relatively simple. If you’re using remote supervision, your incident to workflows must be precise. I guess who supervises, how it’s documented, and where the exceptions apply as precise as you can make all of those, huh? Robyn Johns   Yes, absolutely. Because you are relying on remote supervision, you’ll want to make sure that that is documented very effectively. Kevin Chmura   Yeah, cool. So, what about the OPPS and ASC final rule highlights for 2026? Robyn Johns Yeah. For those that these apply to, there was a 2.6% increase as well in the payment rates. They also expanded hospital price transparency requirements and we’re seeing a lot more attention and probably enforcement in that as well. There was a three-year phase out of the inpatient only list. Site neutral payments were expanded to include Drug Administration Services and the ASC covered procedures list is expanded much in relation to the inpatient only list Phase out. Kevin Chmura Yeah, that that that that’s an interesting one. So the phase out of the inpatient only list is a real operational shift and it’s one of those opportunities for providers to move volume to better cost locations, but really your compliance needs to follow those patients, right and where you’re having them. And so, when your volume moves, audits and education have to move with it, which is probably a challenge and what we know and we at our parent company, at Panacea, price transparency just remains a compliance and reputational priority because failures lead to penalties, but bad data also leads to a lot of scrutiny. So, good that there’s some, you know some guidance there, but it’s clear that those are going to be things that really need to be paid attention to from a compliance perspective. Robyn Johns Yes, for sure. Kevin Chmura So it was hard to watch the news over the last, I don’t know, six to twelve months without talking about the One Big Beautiful Bill Act. So, we’ve been tracking it. I know you’ve been tracking it. So, what’s the timing on practice impacts that you expect? Robyn Johns So most of those One Big Beautiful Bill Act Medicaid requirements that are likely to impact practices, they don’t actually begin until January of 2027. So, practices still have some time to continue their assessment and preparation for those. The immigrant eligibility changes do take effect on October 1st of this year, 2026. So that’s a little bit shorter period of time, but you do have a little bit of time to continue to figure out how that may affect your practice if you have a high number of Medicaid patients, and prepare for the ways that you can offset those eligibility changes and payment requirements. Kevin Chmura Yeah, that clarity on the effective dates really can help teams allocate resources correctly and that’s often a challenge especially when you’re tracking proposed rules versus final rules and not sure when things will go into effect. So that’s good. So, as you’re looking out on the landscape in 2026, what are some of your top compliance priorities that you’re advising organizations to focus on? Robyn Johns Yeah, we’re currently focused on probably five or so top priorities for 2026, not in any specific order, but we are watching data privacy and security. Part of that is because HIPAA updates are underway to both the privacy and security rules, though timelines are unclear. We’re not sure when or i f we’ll see any final rules on those, but we do know that healthcare remains a prime target of cyber-attacks, so we have to constantly be vigilant to that and related to that, but also separately, is AI and other emerging technologies. AI is changing the landscape for the types of attacks we receive, but also the way we have to respond to them. It also is changing the landscape of healthcare generally, both in the provider office and at the payers and at the government. Those other emerging technologies like digital tools, those can increase the compliance risk in your environment, and we need to remember that both government and commercial payers are using AI to identify outlier claims faster and increase their auditing. Then we also have the fraud, waste and abuse enforcement. CMS we know has currently been focused a lot on Medicare Advantage, but that scrutiny can shift oversight over to providers as well because that’s where so much of the data that the Medicare Advantage plans use comes from. The OID also continues to focus on telehealth. There are other focuses are drug device and biologics and program integrity areas such as DME, Hospice and Drug Administration. So, want to make sure that you’re watching all of those if you practice there. Fourth one we have is vendor and third-party oversight. Many of the largest breaches that have we’ve seen have originated with third parties. So, organizations really need to make sure that you have careful oversight and maintain good monitoring on your third-party vendors and others who may have access to your systems and data. And finally, we know we’re going to continue to see those rapid regulatory updates. Federal and state changes often conflict. We have lots of states that are currently in their legislative period. So that will bring out some changes. And then in addition to that, commercial payers are tightening their policies and auditing in response to the pressures that are being put on that on them, whether from the government or just from a financial perspective. Kevin Chmura Yeah, it is something the pace of acceleration of some of the advances in technology and how they how they’re going to impact us. But I guess you know that’s really the reality of 2026 and beyond. You’re going to see an uptick in in in speed to policy changes, faster detection, which will be something and probably more third-party exposure as we rely on more and more vendors and others to help us do what we need to do every day, but I’m sure you know the advice I’ve heard you give many times and we have to agree with it. A strong compliance program has to be built to adapt. That means clear governance, repeatable monitoring and targeted auditing tied to the current risk with an eye on the future and where everything’s going. Robyn Johns Yeah, definitely. It’s an exciting time, lots of opportunities for improving our programs and really tightening things up to make sure that we’re protecting ourselves and all the information that we are responsible for. Kevin Chmura Yeah, great. So, Robyn, thank you for the update and for helping our listeners translate policy movement into practical compliance actions. To everyone listening, if you want the full context and deeper discussion, you can access the webinar on demand at 1st Healthcare Compliance’s website. It’s called Compliance Cliffs: Navigating Telehealth Waivers and Reimbursement Changes. Thank you for listening to 1st Talk Compliance and we’ll see you next time. Thanks, Robyn. Robyn Johns Thanks, Kevin.

Managed Service Providers (MSPs) are encouraged to shift their focus from traditional infrastructure management to becoming Managed Intelligence Providers (MIPs), emphasizing the integration of artificial intelligence (AI) into their service offerings. Chance Weaver, VP of AI Adoption at PAX 8, highlights the necessity for MSPs to engage in deeper conversations with clients about their business processes rather than merely discussing technology tools. This approach aims to identify specific business challenges that can be addressed through tailored technological solutions, including AI, automation, and business intelligence.Weaver notes that while many MSPs have historically excelled in maintaining infrastructure, they often lack a comprehensive understanding of their clients' workflows and business needs. The transition to MIPs involves not only understanding business processes but also ensuring data readiness, which is critical for effective AI implementation. Instead of undertaking extensive data cleanup projects upfront, MSPs should focus on the data relevant to specific business processes, thereby demonstrating immediate ROI and building trust with clients.The episode also discusses the importance of outcome-driven services and the potential for MSPs to monetize AI solutions effectively. Weaver shares insights from his interviews with over 650 partners in the PAX 8 ecosystem, revealing that only a small percentage are currently generating revenue from AI-related services. Successful partners are leveraging their existing relationships and expertise to create value for clients by aligning pricing models with measurable outcomes, thus facilitating a smoother transition to AI adoption.For MSPs and IT service leaders, the key takeaway is the urgency to start conversations about AI with clients, even if they are not yet fully equipped to implement these solutions. By positioning themselves as knowledgeable partners in the AI transformation journey, MSPs can capitalize on emerging opportunities and enhance their service offerings. The discussion emphasizes that while some providers may choose to adopt a fast-follower strategy, those who proactively engage with clients about AI will likely gain a competitive advantage in the evolving market landscape.

Today we find out about the Tirol West region in Austria, plus we look at the best new ski helmets and goggles this winter. We also have an update from the Sheffield Ski Festival, news from Madonna di Campiglio and we hear about a best-ever British performance in the World Cup slalom in Levi.  Host Iain Martin was joined by Simone Zangerl from Tirol West Tourism and ski equipment expert Al Morgan.  --------- Tirol in Austria sponsors The Ski Podcast, which means this winter we're are finding out more about some of the great destinations in Tirol, and how you can connect with the Austrian way of life: ‘Lebensgefühl' – that you'll find there. --------- SHOW NOTES Dave Ryding finished 7th in the slalom at the World Cup in Levi, Finland (4:30) Laurie Taylor recorded the fastest second run to finish in 4th place, just 4/100th of a second off the podium (5:00) Iain spoke with Andrea Busignani about the plan to cap skier numbers in Madonna di Campiglio (6:20) Sam Croft is from the Revive Sheffield Ski Village campaign (9:00) The Sheffield Ski Festival took place on 14-15 November Visit the Tirol West website (10:00) You can travel by train via Zurich to Landeck (10:45) How to travel to Tirol West (11:00) Tirol West includes the towns and villages of Landeck, Zams, Fliess, Tobadill, Grins and Stanz (11:30) Venet is the Tirol West ‘house' resort (12:15) Tirol West is great for ski touring (13:00) You can book a €10 for a return bus transfer to any of St Anton, Lech/Zurs, Ischgl, Serfaus Fiss Ladis and the Kaunertaler Glacier (14:00) There are plenty of walking trails and snow shoeing (16:30) Try ice bathing at Tramser Weiher (17:00) You can enjoy a lot of free activities with the free TirolWest card (17:45) Simone recommends a Tyrolean Groestl (21:00) You can also try the Tiroler Edle local chocolate (21:30) Ski Helmets: ‘Fit is Key' (23:00) For more details on all of the key terms and jargon for helmets, listen to last year's episode (23:30) What does ‘MIPS' mean? (24:00) “If you've got a cheap head, buy a cheap helmet” (30:30) Listen to last year's goggles episode for a breakdown of the key terminology (31:00) What does S1, S2 or S3 lenses mean? (31:15) The Best Skis for Winter 2026 (39:30) The Best Ski Boots for Winter 2026 (39:30) Smith Vantage 2, £235 (26:00) Available in a range of colours, especially the matte black, ultraviolet and Emerald City options. This is a hybrid construction with Koroyd inside, improving shock absorbency, strength and lightweight. These hollow tubes allow a mass of airflow, complemented by the huge number of vents. Add in Mips, the magnetic buckle, Smith's superb AirEvac system, BOA fit adjustment, anti-microbe lining and audio ready earpads, and you're onto a winner. Atomic Revent AMID, £160 (27:30) This series of helmets has a far more contemporary aesthetic than Atomic helmets of recent seasons. It has an in-mold dual shell, so is light with active venting. It has a removable and washable merino and 3m X-Static liner so doesn't develop the smell some helmets can. It has audio ready earpads and the new AMID (Atomic Multi-directional Impact Deflector) tech, combined with a Holo Core EPS liner for enhanced safety.   Bollé Keystone Mips, £120 (29:30) The Keystone is a new model, available in several colours. The minimalist aesthetic looks fab, and in testing we found it very comfortable. It doesn't have loads of vents, but at £120 it's great value. It's available without Mips for £90, but we recommend the added safety of Mips for £30 more. Oakley Flow Scape L Snow Goggles, £325 (32:30)   The Flow Scape has a new conical lens shape giving a dramatically increased field of view (FOV). The lens tilts in towards the face at the base, and is wider and further away from the face at the top. They've even changed the design of the Switchlock lens quick-release system, removing the need for magnets which would have encroached on the FOV. The Vision Rapt face foam is an ultra-memory foam, giving incredible comfort. Even the sliders on the strap have been tweaked to reduce their profile. Each Flow Scape comes with two lenses, one for brighter conditions and the second is the Prizm Iced Iridium, which is one of the best lenses you can get for flat light or stormy conditions. The only downside with this goggle, apart from the cost, is that it will be too large for some.  Head Neves Sunscreen, £330 (34:20) Wow. When we first tried this, we were blown away. The lens tech is next-level. This tint-changing tech covers categories S1-S3 and is solar powered. The solar panel generates a voltage, activating a microprocessor which controls the LCD to darken the lens. It changes tint almost instantly as you move from shade to light and back again.  Scott Ambit LS, £135 (36:00) Ambit is a new goggle design from Scott, including this medium to large fit, as well as the Ambit Compact, which suits smaller face shapes. Scott sells more photochromic lenses, as they cover a range of conditions, saving the hassle of swapping lenses. This Amplifier lens tech provides superb clarity and definition, and we've tested it in stinking, and stellar, conditions, and it always delivers.  Bliz G001, £79 (37:!5) The Bliz Scandinavian minimalist design, married with affordable quality, has impressed us. The G001 and G002 goggles are new for this season, available in adult and small sizes, and the lens is magnetic, for quick swaps. The G001's full frame construction looks almost frameless, whilst the G002 is more traditional, with a chunkier frame. The Smoke S3 lens is a fab choice when the sun's out and looks sensational in this black on white colourway. Mega comfy and excellent value. Feedback If you've enjoyed this episode – or even if you didn't like it – then we'd love to hear from you. You can leave a comment on Spotify, Instagram or Facebook – our handle is @theskipodcast – or drop Iain an email to theskipodcast@gmail.com  You can also follow us on WhatsApp for exclusive material released ahead of the podcast. Antonia Simpson: “I first came across the Ski Podcast at the Snow Show - really enjoyed hearing about Mount Etna! Since then I have listened to lots of episodes: Bladon Lines (252) and James Cove (261) being my favourites. I love your focus on train travel, and in fact will be getting the train in a couple of weeks to Embrun.” Colin Tierney: “I enjoyed episode 263 about Ischgl”  Richard Birlton: "I listen to every podcast and can't wait for it to drop every week" If you're excited about winter, why not visit theskipodcast.com – we have episodes on so many different subjects, interviews with so many people and reviews of so many resorts.  If you'd like to help the podcast, there are three things you can do:    -          you can follow us, or subscribe, so you never miss an episode  -          you can give us a review on Apple Podcasts or leave a comment on Spotify  -          And, if you're booking ski hire this winter, don't forget that you can get an additional discount if you use the code ‘SKIPODCAST' when you book at intersportrent.com or simply take this link for your discount to be automatically applied

In a tech-launch heavy week, Suvi, Josh, and Alex have taken over the pod to chat about what was happening at the recent, season-ending Rouleur Live show, which led them to discuss the value of these cycling exhibitions a little more. To wrap things up, the team chatted through the – admittedly very off-road focused – new product launches from Nukeproof, Ritchey, Velocity USA, and Lazer. If you scroll past the show timestamps, we've also included a little Rouleur Live gallery there for you to browse. Timestamps:00:10 – Intro, and Suvi's Brompton skills04:49 – Rouleur Live: crowds, vibes & venue05:45 – Show tech highlights: Reap aero gravel bike & POC bags10:30 – What are trade shows even for now?15:00 – Industry networking, media value & meeting members20:39 – Nukeproof is back: new Reactor trail bike25:00 – Ritchey Septimer breakaway gravel bike32:00 – Tangent to talk about travel bikes vs hire vs bags39:44 – 32" wheels & the emerging 32er niche46:40 – New Lazer Impala: Dual Core trail helmet, helmet testing, MIPS rivals & Virginia Tech ratings55:00 – Outro

In Episode 504 testen wir ein schickes Santa Cruz Vala AL 70 E-MTB und einen ebenso schicken Urban-Smarthelm, den Neon Mips von Unit 1. Ein Gewinnspiel wartet auch auf euch.

MIps***山ΔΣ

We have relied on PSA for decades, but what's next in precision screening for prostate cancer? In this episode of BackTable Urology, Dr. Jason Hafron from the Michigan Institute of Urology joins host Dr. Ruchika Talwar to discuss the evolving role of biomarkers and artificial intelligence in prostate cancer screening.---This podcast is supported by:Cleveland Diagnosticshttps://www.isopsa.com/---SYNPOSISTogether, Dr. Hafron and Dr. Talwar examine the ongoing challenges of PSA testing and the promise of next-generation blood-based biomarkers, including 4Kscore and IsoPSA tests. They explore how these advancements are reshaping detection, diagnosis, and risk stratification. The episode also highlights how these tools may improve active surveillance protocols, reduce unnecessary biopsies, and better personalize prostate cancer management for better outcomes.---TIMESTAMPS0:00 - Introduction2:23 - Limitations of PSA10:21 - Limitations of MRI18:08 - Overview of Biomarkers (IsoPSA, 4K, PHI, SelectMDx, MIPS, ExoDx)26:30 - Artificial Intelligence---RESOURCESProstate Cancer Screening With PSA, Kallikrein Panel, and MRI: The ProScreen Randomized Trialhttps://jamanetwork.com/journals/jama/fullarticle/2817323 Using IsoPSA With Prostate Imaging Reporting and Data System Score May Help Refine Biopsy Decision Making in Patients With Elevated PSAhttps://pubmed.ncbi.nlm.nih.gov/36965817/ Clinical validation of IsoPSA, a single parameter, structure-focused assay for improved detection of prostate cancer: A prospective, multicenter studyhttps://pubmed.ncbi.nlm.nih.gov/35840465/

In this episode of Talking Sleep, host Dr. Seema Khosla welcomes Dr. Doug Kirsch, Medical Director of Atrium Health Sleep Medicine and Clinical Professor in the Department of Neurology at Wake Forest School of Medicine, and Dr. Fariha Abbasi-Feinberg, president-elect of the AASM and private practice physician with Millennium Physician Group in Fort Myers, Florida, to introduce PLATO—a groundbreaking longitudinal assessment tool for obstructive sleep apnea. The Epworth Sleepiness Scale has been a cornerstone of sleep medicine practice for decades, yet clinicians universally acknowledge its limitations in capturing the full patient experience. Similarly, PAP adherence—while important and part of Medicare's MIPS program—tells only part of the story about treatment success. During his AASM presidency, Dr. Kirsch recognized the need for a more comprehensive metric and convened an expert advisory panel to develop a better solution. The conversation traces PLATO's development journey, which Dr. Rosen described as "Doug's baby with a prolonged gestation." Starting with 44 potential questions and utilizing the ICON methodology, the panel carefully refined the tool to capture domains beyond simple sleepiness—including quality of life, functional impairment, and symptom burden that the Epworth overlooks. Dr. Kirsch and Dr. Abbasi-Feinberg explain the validation process, how the tool discriminates between OSA severity levels, and why certain seemingly similar questions about sleepiness were all retained. The episode addresses practical implementation questions: How is PLATO scored? Why do the first two sections use 5-point scales while the final section uses 10 points? Is it free to use, and how does one access it? Will it integrate into electronic health record systems like Epic? Most importantly, how should clinicians use this tool—will it replace the Epworth for Medicare requirements, or does it serve a different purpose? The discussion also explores how PLATO relates to the recent AHRQ report on OSA treatment outcomes and why the tool focuses on patient-reported symptoms rather than solely cardiovascular endpoints. Dr. Kirsch shares his vision for PLATO's future, including hopes for foundation grants to further study the tool and demonstrate that treating OSA and its associated sleepiness meaningfully improves patient outcomes. Whether you're frustrated with current assessment limitations, interested in value-based care metrics, or seeking better ways to document treatment efficacy beyond adherence data, this episode provides essential insights into a tool that may reshape how we measure success in sleep medicine. Join us for this important discussion about moving beyond PAP adherence and Epworth scores to truly capture what matters to our patients.

To kick off the Best Of AWadd Radio, Commander's Crosstalk as always with guest Michael Phillips on the show next as we kick off a show full of previews for tonight's Washington Commanders game. Commanders Corner on the show next as we preview tonight's game and AWadd gives out his MIPs for today's game. AWadd takes us into The Richmond Commander on the show next as he covers all of the top storylines around the game as injuries are gonna change top targets. David Harrison joins AWadd on the show next for more Commander's coverage as we break down tonight's game as there is a question of game status for many players. Commanders Keys To Victory on the show next as AWadd gives out the three things Washington is going to need to take down Chicago at home tonight.

AWadd brings us into the show as always as we open up The Sports App breaking down the biggest moments and stories from the weekend out of the NFL, College Football, the MLB, and in the NHL. Commander's Crosstalk as always with guest Michael Phillips on the show next as we kick off a show full of previews for tonight's Washington Commanders game. Commanders Corner on the show next as we preview tonight's game and AWadd gives out his MIPs for today's game. Weekend Recap on the show as AWadd enjoyed the Richmond Folk Festival and Stub made a trip to Boston this weekend.

Mountain biking is full of thrills—and spills. In this episode, we dive into the latest innovations in helmet protection that are changing the way riders stay safe on the trail. From advanced impact-absorbing materials to rotational force reduction systems like MIPS and beyond, we'll explore how cutting-edge technology is helping protect brains from serious injury. Whether you're a weekend rider or a downhill racer, this conversation will give you the knowledge you need to ride with more confidence and understand what makes today's helmets smarter, safer, and stronger.

Title: MIPS for ICH: Ground-breaking Innovation for MIS ICH Evacuation and Future Directions Guests: David Dornbos and Mark Bain MIS ICH evacuation has become standard of care following the ENRICH trial and the introduction of level 1 evidence showing efficacy. We discuss the pearls and pitfalls of this approach and how to best build systems of care to enhance its success. While this has been a frameshift in ICH management, numerous questions remain unanswered and are the focus of ongoing trials and research. Sponsored by Stryker

Hier geht's zu unserer neuen Analyse-Plattform für mehr Deep-Dive-Content zu Einzelaktien, einer Transkript-Datenbank, Branchen-Deep-Dives und und und. Mit diesem Code ist der erste Monat kostenlos: https://herohero.co/oaws/invites/RZJXWTIYRE Ohne Aktien-Zugang ist's schwer? Starte jetzt bei unserem Partner Scalable Capital. Alle weiteren Infos gibt's hier: scalable.capital/oaws. In SpaceX investieren? EchoStar macht's möglich & versenkt dabei die Deutsche Telekom. In Mistral investieren? ASML macht's möglich. VW, QuantumScape und Xpeng haben gute IAA. Summit hat schwache Daten. BioNTech dadurch auch. Eightco steigt 4000%. Ist Miniso (WKN: A2QE9X) das nächste Pop Mart? Helme mit 50% operativer Gewinnmarge? Das ist das Ziel von MIPS (WKN: A2DNT6). Diesen Podcast vom 09.09.2025, 3:00 Uhr stellt dir die Podstars GmbH (Noah Leidinger) zur Verfügung.

In this episode, Jennifer Oelenberger, President of EHR Concepts, joins us to share the MIPS 2025 framework in plain language—along with strategies to improve category scores, avoid common pitfalls, and make MIPS part of your everyday workflow.Learn more about Medcurity: https://medcurity.com Visit EHR Concepts: https://ehrconcepts.com #Healthcare #Cybersecurity #Compliance #HIPAA #SecurityRiskAnalysis #RiskManagement #MIPS

Dmitry Grinberg joined us to talk about running Linux on small microprocessors (physically small and/or 4-bit). Dmitry does this by emulating a MIPS processor. Boot times vary between minutes and days, depending on the processor.  Dmitry's projects are on his website (dmitry.gr) including: 8-pin Linux (Cortex-M0+!) Linux on an 8-bit micro? Linux/4004 Dmitry recommended NandGame, an online game about building up a processor. We mentioned Eric Schlaepfer of TubeTime. He was on the show on 419: Fission Chips, with EMSL's Windell Oskay, talking about their book Open Circuits. Transcript Mouser Electronics has a dedicated Empowering Innovation Together hub that covers the latest breakthroughs in tech. Their new series explores how AI is reshaping engineering—from design automation to rapid prototyping and predictive maintenance. You'll find insightful articles, podcasts, and videos that showcase real-world applications across industries. If you're ready to see how AI is powering the next generation of engineering, head over to Mouser.com/empowering-innovation.

In Episode 495 zeigen wir euch den Test eines Haro Daley Alloy Limited 1 Trailfullys. Außerdem nehmen wir euch mit zu Mips und zeigen euch in Theorie und Praxis was es mit dem Sicherheitssystem für Helme auf sich hat. Zu gewinnen gibt es auch etwas.

In this episode, Ben Bajarin and Jay Goldberg discuss the recent developments in the RISC-V ecosystem, including Global Foundries' acquisition of MIPS and the implications for the semiconductor industry. They also delve into Intel's challenges with its manufacturing processes and the shifting landscape of AI, highlighting the potential for both growth and caution in the current market dynamics.

It's a Raspberry Pi flavored show, with PiBoot improvements, and a really slick looking Raspberry Pi Laptop from Argon Fourty. System76 isn't to be left out with a new powerhouse laptop of their own. There's AMD Raytracing improvements, an acquisition in the Processor space, and an exciting new OBS release. For command line tips we talk about Proxmox scripting, ProtonPlus, and the ldd tool for Listing Dynamic Dependencies. You can find the full show notes at http://bit.ly/44EEdnP and enjoy! Host: Jonathan Bennett Co-Hosts: Rob Campbell and Jeff Massie Download or subscribe to Untitled Linux Show at https://twit.tv/shows/untitled-linux-show Want access to the ad-free video and exclusive features? Become a member of Club TWiT today! https://twit.tv/clubtwit Club TWiT members can discuss this episode and leave feedback in the Club TWiT Discord.

video: https://youtu.be/aig4jdVoL6o Comment on the TWIL Forum (https://thisweekinlinux.com/forum) This week in Linux, we have another jam packed episode of TWIL. Red Hat announced No-Cost RHEL for business developers, MIPS has been acquired, the Bazzite team have a brand new app store, and we have new releases from Thunderbird, OBS Studio, Bash and more! All of this and more on This Week in Linux, the weekly news show that keeps you up to date with what's going on in the Linux and Open Source world. Now let's jump right into Your Source for Linux GNews! Download as MP3 (https://aphid.fireside.fm/d/1437767933/2389be04-5c79-485e-b1ca-3a5b2cebb006/d91f1a56-0ece-4e0b-ac35-7747be11678d.mp3) Support the Show Become a Patron = tuxdigital.com/membership (https://tuxdigital.com/membership) Store = tuxdigital.com/store (https://tuxdigital.com/store) Chapters: 00:00 Intro 00:36 Red Hat Announces No-Cost RHEL For Business Developers 03:42 GlobalFoundries acquires MIPS 05:33 Bazzite gets new app-store & devices 09:34 Sandfly Security, agentless Linux security 11:38 OBS Studio 31.1 Released 14:30 Mozilla VPN Linux App is Now Available on Flathub 18:04 Thunderbird 140 Released 21:06 Bash 5.3 Released 22:03 Outro Links: Red Hat Announces No-Cost RHEL For Business Developers https://www.redhat.com/en/about/press-releases/red-hat-introduces-red-hat-enterprise-linux-business-developers-aligning-application-development-production-consistency (https://www.redhat.com/en/about/press-releases/red-hat-introduces-red-hat-enterprise-linux-business-developers-aligning-application-development-production-consistency) GlobalFoundries acquires MIPS https://mips.com/blog/mips-and-globalfoundries-powering-the-next-wave-of-physical-ai/ (https://mips.com/blog/mips-and-globalfoundries-powering-the-next-wave-of-physical-ai/) https://gf.com/gf-press-release/globalfoundries-to-acquire-mips-to-accelerate-ai-and-compute-capabilities/ (https://gf.com/gf-press-release/globalfoundries-to-acquire-mips-to-accelerate-ai-and-compute-capabilities/) Bazzite gets new app-store & devices https://universal-blue.discourse.group/t/bazzite-july-2025-update-bazaar-z13-kernel-6-15-steam-hardware-survey/9501 (https://universal-blue.discourse.group/t/bazzite-july-2025-update-bazaar-z13-kernel-6-15-steam-hardware-survey/9501) Sandfly Security, agentless Linux security https://thisweekinlinux.com/sandfly (https://thisweekinlinux.com/sandfly) OBS Studio 31.1 Released https://github.com/obsproject/obs-studio/releases/tag/31.1.0 (https://github.com/obsproject/obs-studio/releases/tag/31.1.0) https://www.omgubuntu.co.uk/2025/07/obs-studio-31-1-whats-new (https://www.omgubuntu.co.uk/2025/07/obs-studio-31-1-whats-new) Mozilla VPN Linux App is Now Available on Flathub https://flathub.org/apps/org.mozilla.vpn (https://flathub.org/apps/org.mozilla.vpn) https://www.omgubuntu.co.uk/2025/07/mozilla-vpn-linux-app-available-flathub (https://www.omgubuntu.co.uk/2025/07/mozilla-vpn-linux-app-available-flathub) Thunderbird 140 Released https://blog.thunderbird.net/2025/07/welcome-to-thunderbird-140-eclipse/ (https://blog.thunderbird.net/2025/07/welcome-to-thunderbird-140-eclipse/) https://www.thunderbird.net/en-US/thunderbird/140.0esr/releasenotes/ (https://www.thunderbird.net/en-US/thunderbird/140.0esr/releasenotes/) Bash 5.3 Released https://www.gnu.org/software/bash/bash.html (https://www.gnu.org/software/bash/bash.html) https://www.omgubuntu.co.uk/2025/07/bash-5-3-new-features (https://www.omgubuntu.co.uk/2025/07/bash-5-3-new-features) https://lwn.net/Articles/1029079/ (https://lwn.net/Articles/1029079/) https://www.phoronix.com/news/GNU-Bash-5.3 (https://www.phoronix.com/news/GNU-Bash-5.3) Support the show https://tuxdigital.com/membership (https://tuxdigital.com/membership) https://store.tuxdigital.com/ (https://store.tuxdigital.com/)

In this episode, I sit down with Greg Shapleigh, who came highly recommended by multiple previous guests as someone I absolutely had to interview. Greg's journey in the cycling industry is remarkable - he started as a shipping clerk at Giro after moving to Santa Cruz to pursue bike racing, but quickly found himself pulled into marketing and product development discussions. Over three decades, he's shaped some of cycling's most iconic brands and products, from Giro's revolutionary helmets to the creation of Fizik saddles.What makes Greg unique is his disciplined, values-driven approach to brand building, heavily influenced by mentorship from "Good to Great" author Jim Collins. We dive deep into his philosophy of focusing on core values rather than chasing opportunities, his experiences at companies like Specialized and Santa Cruz, and how he identifies stagnant product categories ripe for innovation. Greg shares invaluable insights on building teams, making strategic decisions, and the delicate balance between staying true to your brand and achieving growth.00:00 Introduction to Greg Shapley01:40 Greg's Early Life and Career Beginnings08:26 Discovering Cycling and Moving to Santa Cruz10:36 Starting at Giro and Early Marketing Involvement15:59 Transition to Marketing Manager at Giro18:24 Collaboration with Jim Collins and Business Philosophy25:10 Giro's Acquisition by Bell Sports32:23 Innovations and Expanding Product Lines38:48 Market Cycles and Product Innovation39:34 Understanding Product as a Concept40:41 Brand Values and Business Success41:48 Giro's Approach to Product Development43:52 Expanding into New Categories46:27 Career Transitions and Business Philosophy50:00 The Importance of Values in Business52:36 Challenges in Brand Positioning54:00 Consulting and Brand Strategy01:12:20 Specialized: A Case Study01:17:58 Final Thoughts and Contact InformationRead the latest 'The Business of Cycling' BlogSign up for 'The Business of Cycling' Newsletter

Success doesn't happen by accident—it's a journey we must own, and that begins with the right mindset. Ryan Walsh, Co-founder and Chief Strategy Officer at Pax8 discusses the power of strategic leadership, embracing innovation, and the importance of cultivating community within the channel. From his rock-climbing analogy of navigating challenges to his passion for helping MSPs grow through “guided growth” and “amplifying uniqueness,” Ryan underscores the need for focused vision and teamwork. Highlights also include: A glimpse into the Voyager Alliance partner program. The expanding influence of AI, agents, and a shift to managed intelligence partners (MIPs). To be competitive means owning a niche, staying connected, and thinking collaboratively. Family and basketball as foundational to his leadership philosophy. His leadership philosophy, rooted in enabling others and fostering shared success, offers valuable lessons for anyone seeking to lead with purpose in a rapidly changing tech landscape. Follow Ryan on LinkedIn and visit Pax8.com to stay informed about the marketplace. Timestamps: [08:21] Father modeled passion [18:03] Voyager Alliance Growth Tracks [18:57] Owning your niche [23:05] Power of Team --- more --- If you want to master the art of audience engagement while learning how to conquer speaking anxiety, deliver persuasive presentations, and close more deals, this is the program for you. Twins Talk It Up is hosted by identical twin brothers Danny Suk Brown and David Suk Brown, who share leadership communication strategies designed to help professionals embrace the power of their authentic voice. Together, we'll explore tips and tools to unlock the full potential of your voice, dominate every stage you step onto, and elevate your influence and value. Along the way, we'll crush goals and share plenty of laughs. Book a Free 15-minute discovery call: dsbleadershipgroup.com/schedule-a-call/ Website: appmeetup.com/twinstalkitup/ Community: facebook.com/groups/publicspeakingpoints Patreon: patreon.com/twinstalkitup

Wir berichten heute neben Tech-Neuheiten auch von unseren Events der letzten Wochenenden: Ingo ist die 300 km der Mecklenburgischen Seenrunde gefahren und André ist das 24h Brelinger Berg Event. Dazu geht Ingo auch ausführlich auf seinen selbstverschuldeten Sturz ein. Den er sich bis heute nicht erklären kann, bzw. nach Erklärungen sucht. Aber wichtig: Allen geht es gut, es ist nichts ernstes passiert. Dabei half auch der Sweet Protection Falconer Helm, der den heftigen Aufprall dank MIPS perfekt absorbiert hat. Dazu News: Shimano reine Funktschaltung ist auf den Markt gekommen. Leider nicht die GRX, es ist die XTR, die als erstes komplett auf Funk umgestellt wurde. Dazu Campagnolos 13-fach Super Record: doch sehr geil geworden, die Gruppe. Mit tollen Gangabstufungen. LINKS ZUR SENDUNG: Unser Jaegher Event: https://www.enjoyyourbike.com/store-hannover/community-rides/ 
RTF in Lehrte: https://rc85.de/rtf-2025 24h Brelinger Berg: https://www.24h-brelinger-berg.de/ Mecklenburger Seenrunde: https://www.mecklenburger-seen-runde.de/de Podcast mit Veranstalter: https://www.youtube.com/watch?v=LHtfhSJujuw Ingos Helm: https://www.enjoyyourbike.com/sweet-protection-falconer-aero-2vi-mips-helm-satin-white-94234892?number=94234892 Campagnolo Super Record 13-fach: https://www.rennrad-news.de/news/campagnolo-super-record-13-fach-infos-preise/ Unser Video zur XTR: https://youtu.be/hOU3vUEUXIM?si=wSEZMJxJRny08WI0 Pick(s) Ingo: MB AIR Powerbank: https://www.nitecore.de/nitecore-powerbank-nb-air-5000mah/nc-nbair
Kabel dazu: https://www.nitecore.de/nitecore-nlink-10-usb-c-ladekabel-60w/nc-nlink
Satechi Ladepuck Apple Watch: https://satechi.net/products/usb-c-magnetic-charging-dock/Z2lkOi8vc2hvcGlmeS9Qcm9kdWN0VmFyaWFudC8zMTk3MjMyNDc2OTg4MA== Peak Design Hüfttaschen: https://www.enjoyyourbike.com/peak-design-outdoor-sling-2-liter-black-94235294 
Pick André:
FPW Drohnenpilot
 INHALT 00:00:00 Habe leider vergessen zu sagen, dass es um XTR/GRX und Campagnolo geht 00:01:36 Jaegher Event am Freitag: Vorbeikommen & Räder probefahren 00:06:13 RTF in Lehrte an Himmelfahrt: hinfahren! 00:16:33 Andrés Bericht vom 24h Rennen Brelinger Berg 00:30:19 Kurzer Urlaubs-Bericht Grömitz und WIDE als Idealsetup (oder CONCEPT?) 00:39:42 Ingos Mecklenburgische Seenrunde Bericht 00:57:59 Ingos Sturz: Bericht & Unsicherheit, wie und warum es passiert ist 01:30:54 Campagnolo Super Record 2-13-fach: doch geiler als gedacht! 01:43:21 Shimano geht auf Funk: Keine GRX, aber nach 7 Jahren neue XTR 02:06:16 Ingos Test der neuen Garmin Forerunner 970: leicht, hell, laut, Akku schwächer 02:26:00 Pick(s) Ingo: Nitecore NB Air Mini-Powerbank, Peak Design Outdoor Tasche 02:39:28 Pick André: schnelle Drohnen 02:51:43 Post-Show: Veloforte Riegel & Fuji GFX 100 RF Mittelformat-Kamera 03:07:32 Pre-Show: KI scheitert an Erstellung einer Pick-Liste

Would you rather replace a battery if you can or just get a new thing? Gym replaces a solenoid and Foo cleans up his misters. Foo troubleshoots a starting issue with his motorcycle while Gym has trouble with a battery on a Honda Odyssee. Do you have any weird batteries you have a hard time finding? Gym finally gets his Oakley DT3 helmet in large. Piper graduates and keeps it low-key while turning 21 on the same day. Have you ever been iced? Foo mixes drinks. Gym explains how Rog is doing. Plus more!

Dr. Luis Raez and Michael Reff share the newest update to the medically integrated dispensing pharmacy standards from NCODA and ASCO. They review updates to domain one, on key patient-centered quality standards on health equity and social determinants of health, drug access, patient safety, education, and adherence to maximize treatment outcomes and domain two, on key operational quality standards on logistics, care coordination, and waste prevention. We also cover the impact of these updated standards for clinicians, oncology practices, and people receiving oral anti-cancer medications. Read the complete standards, “Medically Integrated Dispensing Pharmacy: ASCO-NCODA Standards.” Transcript These standards, clinical tools, and resources are available on ASCO.org.  Read the full text of the guideline and review authors' disclosures of potential conflicts of interest in the JCO Oncology Practice. Brittany Harvey: Hello, and welcome to the ASCO Guidelines podcast, one of ASCO's podcasts delivering timely information to keep you up to date on the latest changes, challenges, and advances in oncology. You can find all the shows, including this one, at asco.org/podcasts.  My name is Brittany Harvey, and today I'm interviewing Michael Reff from the Network of Collaborative Oncology Development and Advancement and Dr. Luis Raez from Memorial Cancer Institute and Florida Atlantic University, co-chairs on "Medically Integrated Dispensing Pharmacy: American Society of Clinical Oncology – Network of Collaborative Oncology Development and Advancement Association Standards Update." Thank you for being here, Michael and Dr. Raez. Dr. Luis Raez: Thanks for inviting us. Michael Reff: Thank you for having us. Brittany Harvey: Then, before we discuss these standards, I'd like to note that ASCO takes great care in the development of its standards and ensuring that the ASCO Conflict of Interest policy is followed for each guidance product. The disclosures of potential conflicts of interest for the expert panel, including Michael and Dr. Luis Raez who have joined us here today, are available online with the publication of the standards in JCO Oncology Practice, which is linked in the show notes. So then, to dive into the content here, Michael, I'd like to start with what prompted an update to these ASCO-NCODA standards and what is the scope of this update? Michael Reff: Thank you, Brittany. What led NCODA and ASCO to endeavor in this, and it started back in 2019 as the amount of oral anticancer medications became more and more prevalent in cancer treatment, we saw the need providing a blueprint for excellence in care for patients prescribed oral anticancer medications, specifically in the outpatient setting. And the update was driven by the rapid growth of these oral oncolytics starting back in the mid to late 2015 through 2019 or so, and then continued on into the 2020s where we are today. We saw the increase in the complexity of the management of these patients with these therapies basically outside the traditional clinical settings. And we wanted to make sure that with more cancer treatments that are taken at home than just at the clinic, like in the oral setting, new challenges had emerged around patient safety, access, adherence, and overall treatment success. The updates now address patient-centered and operational interventions designed to improve access, safety, quality, accountability, and outcomes of oral anticancer and other supportive care medications prescribed for the cancer patient. Dr. Luis Raez: As Mike said, these guidelines help improve patient care tremendously, but also help us a lot as an oncologist, you know, community oncologists that- now that we have opportunity to dispense these oral oncolytics, we need help to create our medical integrated pharmacies, and NCODA is providing here a way that, how to do this safely, efficaciously, good quality, you know? So that's why I think we always do everything for the patients, but also this helps a lot to the doctors. And there are a lot of what we call specialty pharmacies or medical integrated pharmacies now nationwide. Michael Reff: I'll build on what Dr. Raez had mentioned. This is the impetus. If you looked at the innovation that was coming from the pharmaceutical companies, many of it coming in the oral form for anticancer medications, and based on that, taking a look at the infrastructure that is in place in these practices, whether it's in the community or the IDN or health system settings, this amount of innovation that was coming needed to be addressed by taking a look at the medically integrated oncology team. And these standards address not just the pharmacy component, but also the whole continuum of care, starting with a medical oncologist or the hematologist, with the pharmacists, nurses, the pharmacy technicians, others that are involved in the care of the patient. And there were no standards involved. And when we approached ASCO back in 2018 to eventually publish the first version of these standards, the need was identified, and we worked collaboratively with ASCO to create the first set and then the revisions as we talked about. One thing to note regarding the revision plus the original standards, we had a cross-section of the care team on the committee, and we did that very purposefully. So, the ASCO-NCODA team curated a committee to help develop these original standards and the revision of these standards with medical oncologists both from community and health systems, pharmacists from both community and health systems, and also nurses. And we also included a patient that currently has and currently receives oral anticancer medication. And so NCODA and ASCO are very proud of the committee that we put together because of the experts in their field, but also extended the invitation to a current patient. And we embedded everybody's expertise in the curation of these standards. Brittany Harvey: Absolutely. I appreciate that background and context and how it's critical to improve patient care. And these standards really help oncologists, and we're looking across the continuum of care to provide optimal care for our patients. So then next, Dr. Raez, I'd like to review the key points of the revised standards for our listeners. So for Domain 1, what are the key patient-centered quality standards on health equity and social determinants of health, drug access, patient safety, education, and adherence to maximize treatment outcomes? Dr. Luis Raez: Yeah, this was a great effort, you know, at the multidisciplinary team. And as you can read in the standard, there were more than 240 publications reviewed; more than 55 of them are quoted here. And the standards are in two groups, as you said. With the group one, I'll briefly mention some of them. For example, SDOH, social determinants of health, is very important because as doctors, we prescribe, and sometimes patients don't get the medication, you know? And we prescribe assuming that 100% of the patients will get the medication. But something simple like the patient doesn't have insurance, the patient is underinsured. I have a patient that we didn't have an address to send the medication because he's homeless. Something that as a doctor you say, "Oh, oh my God, this is outside my realm," but it's not outside reality. So that's why, even if we don't think that this is part of our expertise dealing with social determinants of health, the fact that the patients have food insecurity, they don't have transportation, they don't have insurance, they don't have a caregiver, impact tremendously in the outcomes of the therapy. So that's why, basically, in this standard, we want to call attention that SDOH, social determinants of health, needs to be identified. There are in the literature countless examples of why this is important. For example, in the guidelines, we quote two or three examples of prostate cancer studies that, for example, we quote a study of 27,000 people with prostate cancer that were taking oral oncolytics, and how come the fact that the elderly, seniors, the fact that they have high prescription costs, and how all of this affected the adherence to the medication. And that's why it's important to identify the SDOH. And in other sections of the guidelines, we said how to address them, no? Another important thing in this domain is the cultural, you know, we need to be culturally sensitive and to take care of all of these social factors. For example, here in South Florida, we deal with the Haitian culture, Filipino culture, Latin culture, and American culture, and it's a blend, but it's not easy to go from one to the other. Another one is the fact that we have to include new technologies. A lot of patients, for example, we use EMR, EMR Epic, and now Epic has everything in the phone. The fact that we can have now the patient can see her prescription medication over the phone, the fact that they can use the phone to request from you a refill, and from your phone, you send the refill to the pharmacy, and you notify from your phone to the patient that the refill is sent, and the patient can check in his phone that the refill is ready. These things are amazing because that's why it's important that we incorporate these technologies to the patient care, and in this specific case, of dispensation of oral therapies, no? Another crucial point is education. You cannot be sending a patient a package of 300 pills without education. So that's why in our guidelines, mainly pharmacy, clinical pharmacies, or in some centers like mine, we have advanced practice providers, it's mandatory in our centers to have like a one hour of education before you send the prescription. So the patient is aware about side effects and contraindications, all of these things. They provide them also materials and also consent. You know, in the old times, you don't give chemo without a consent. Now, a lot of people say, "Oh, it's only a pill." There is a lot of benefits or side effects that can come from the pill, so you need to consent everybody, you know? So, another aspect is adherence. I already told about that, but we need to provide patients with a baseline assessment, no? So, you cannot send again the prescription and hope, "Oh, I'll figure it out what happened next month when the patient comes back." I tell you, the patient is homeless, where are you going to send it? If the patient is telling you, "I don't have insurance," what good is it for you to send a prescription? The patient will not get it. So that's why you need to do a baseline assessment of adherence. You need to do a calendar. You need to do electronic support, I mentioned already with the EMR and the phones. For example, my MIP, my specialty pharmacist, sends me a message in the EMR, "Dr. Raez, the insurance is not covering, the patient has a high copayment, we are going to delay the dispensation of the medication." So there needs to be a communication. Or sometimes there is a confusion with the insurance, and I cannot wait for the poor patient to call three, four weeks later, "Oh, I didn't get the medication," to know what happened, no? My MIP is very good. They send the clinical pharmacist a message, "Hey, you know, the insurance doesn't believe that the pill is adequate, or you need to provide more documentation. You need to prove the mutation, the genetic aberration." So if you provide us that, the insurance may approve. So that communication with the doctor is very important to improve adherence. And one important thing that we have in this one that we didn't have in the anterior is the tracking of outside medications. A lot of times you say, "Okay, the insurance allowed us to provide the medication it's 100% responsible." But then the insurance says, "Oh, no, no, don't worry. CVS will provide the medication." So it says, "Well, it's you know, it's not my responsibility. CVS will provide the medication, they have to take care." But we know that outside our specialty pharmacies or MIPs, the care is not very good. So that's why we are taking our ownership that, "Okay, the insurance said the patient will get the medication from some outside pharmacy." But our clinical pharmacists track that. What happened? Did the patient get it? The patient didn't get it. The copayment is still high. So even if you get the medication from somewhere else, if the copayment is high, we, our clinical pharmacists, help the patient to navigate and get the foundation or the copayment or finally the maker, the industry partner, provides the drug for free, but somebody needs to do the paperwork. And that's why this is very important. We cannot abort our responsibility because, "Oh, the insurance said somebody else will give it." I work for the public healthcare system, so my patients, some of them don't have insurance, they are underinsured. So we see these problems every day. And finally, the standards talk about the importance of safety, documentation, verification, monitoring, refills, you know, you need to keep track of refills. We already mentioned how important is the technology to facilitate the refills, and the quality. Brittany Harvey: Yes, thank you for touching on those highlights for Domain 1. It's important that all patients have access to care and these oral anticancer medications, and not only just access to care, but safe and effective care. It's really important, as you mentioned, Dr. Raez, to meet patients where they're at and incorporate technology. And I also want to note the coordination with external pharmacies that you mentioned in tracking outside medications as well. It's not only important for multidisciplinary care within the oncology practice itself, but also external to the oncology practice. That's why we put together this multidisciplinary panel to develop these standards. So then, expanding on that, Dr. Raez, for Domain 2, what are the key operational quality standards? Those on logistics, care coordination, and waste prevention. Dr. Luis Raez: Yeah, we have a lot of standards here, but maybe we can summarize in five or six points, no? For example, financial toxicity in cost and waste are very important because the patients, yeah, you put them on therapy, but as you can understand, if there is disease progression, the patient don't need the medications. And sometimes you get refills even if the patient has disease progression. If you do a dose reduction, the same problem. Or you discontinue medication and the patient keeps getting the drugs. So, you're talking about drugs that are between 20 and 30 thousand dollars per month. This is a lot of money. There are studies that we're quoting in the standards that the waste could be from 1 to 3 or 4 thousand per patient, no? Another aspect is dispensing. When you dispense the medication, this is not as easy as, "I'll ship to your house a bag of medications." You know, there needs to be a diagram, a decision tree. You need to train the staff to know what we're doing. There needs to be an auditing of the process. They need to be even packaging and shipping, you know? For example, I'm in Florida today and outside in summer it's going to be 95 degrees. So, everybody leaves the package outside your house, and sometimes you go the whole day until when you come at 6:00 p.m. There are medications that cannot be left outside there, you know? I don't know, it sounds like a joke, but I have a patient that the medication used to be stolen because people thought that that was something important, you know? And of course, it's important because it's a $20,000 medication. So, the poor patient, because he lives in an area that is not safe, has to come and pick up in person. All of these things sound very trivial, but that's real life that affects adherence. Another important thing is shortage. This is something that we just suffered two or three years ago, and we have to think about what happens in the next shortage. What happens if there's going to be a shortage? What do we do or how are we going to do that? Now we know it's something that is happening probably very soon again, and something that we have to consider. Another standard is the care coordination. You need to have probably, if it's possible, a coordinator. I know that for small practices it's very hard, but for big cancer centers, you should have a coordinator of this. I already mentioned before, the communication between the physicians and the doctors to coordinate the care, no? You need to write the prescription again, you need to provide more information, or to be notified, "Hey, you know, the patient is throwing up in the first week, you need to see the patient, please," no? So, this type of communication needs to exist so we can serve the patient better. It's also important, you know, we're improving quality and we're improving care. It's important to try to collect patient-reported outcomes. This is something that now we have the opportunity, if we do things well, to do it and show that we're providing a better care. The other thing is that we already mentioned SDOH in the other standard. In this standard, we mention mainly SDOH to partner. For example, we collect in my center SDOH, and I always get frustrated when the patient doesn't have transportation. But I didn't know that there are local institutions that provide free Uber rides, free Lyft rides. So that's why it's important to partner with these institutions. I have a local grocery chain that provides free food for the patients, and I didn't know that. It's important to be aware what the patient needs and what resources do you have to fulfill the SDOH. That's the part that we mention in here. So that's why, in summary, those are the six probably most important points here. I'll ask Mike for some comments. Michael Reff: Thank you, Dr. Raez. Brittany, to answer your question, and as was pointed out on logistics, care coordination, and prevention of waste, certainly that is an aspect that has changed in the revision that we're here to talk about. There's really two components to waste, and it's cost avoidance and then waste prevention. And as Dr. Raez mentioned several times, the importance of the medically integrated team and having the ability for that practice to fill that prescription internally and have robust documentation. Cost avoidance is a critical component that the medically integrated pharmacy, or the MIP, can help the total cost of care. And that is by preventing errant fills or waste that can occur by intervening in the care of the cancer patient, as we do every day. But when the practice has access to the medication and can fill that prescription in-house in the medically integrated pharmacy, that team, that care coordination that takes place, can prevent those errant fills or additional fills when there's dose reductions, there's holidays, there's things that happen in real time. And it's impossible for a mail-order pharmacy that's in another state that has lead times, when a prescription needs to be mailed 7 days or 10 days before the patient will run out of the medication, it's impossible for them to logistically coordinate that care like we can internally within the medically integrated pharmacy. So, we prevent waste and overall cost of care by cost avoidance and having that coordination or that continuity of care that we talk about. And we prevent waste from the mail-order pharmacies by taking that prescription internally and filling it, but also doing it in a way that's more sustainable and cost-effective for all stakeholders in the oncology ecosystem. Brittany Harvey: Absolutely. Thank you both for reviewing those key standards for Domain 2 and touching on the importance of distribution logistics and all the things that a medically integrated pharmacy needs to think through in getting oral anticancer agents to patients. Following that, Michael, we've touched on this a little bit earlier, but how will these updated standards impact clinicians and oncology practices? Michael Reff: Yes, and as Dr. Raez and I have discussed throughout this podcast, these additional standards are there to help support that continuity of care by educating the clinicians that are in the oral anticancer medication space to elevate their provision for these oral therapies. What I mean by that is the practice has to perform at a certain level in order for them to, as I call it, deserve the right to fill that prescription by having the processes and procedures in place. And these standards, these updated or revised standards, are the blueprint for better patient care and to help the practices execute on that journey of continuous improvement. Dr. Luis Raez: Yeah, I only want to add, we have practical examples in the guidelines. We quote a couple of studies that have been successful. And this year, for example, I am a lung cancer doctor, we are presenting in World Lung our standards of adherence to oral oncolytics for EGFR therapy, following the NCODA-ASCO standards. We're around 95% of adherence. We are a healthcare system that is public. We have people with no insurance and a lot of social determinants of health. We are trying to show that it's feasible, even in the most difficult circumstance, when you follow the standards, to be successful. Brittany Harvey: Definitely, these standards can help clinicians and oncology practices succeed in providing these medications. So then beyond that, and to wrap us up, Michael, what do these revised standards mean for patients who are receiving oral anticancer medications? Michael Reff: Yes, great point and question, Brittany, because we have covered the benefits to the clinicians and the practices themselves. But how is this going to support better patient care? And it does it in a whole host of ways. I'll cover just a few of them. What I'm about to share with you relates back to what we call at NCODA the "core claims." Like, what's the core claims of having a medically integrated pharmacy within the practice? And there are seven different core claims that we feel practices that are focused on the continuity of care can deliver better outcomes that are embedded in these standards. And it's talking about abandonment, adherence, access and affordability, speed to therapy or time to fill, as we call it, education, patient satisfaction, and cost avoidance that we covered earlier. So those are the core claims that a practice that follows these revised standards can help elevate. So, faster and more affordable access to the oral cancer medications; individualized support to address barriers like transportation, finance, language, or health literacy, and so on; clear, patient-friendly education; something that is near and dear to all clinicians' hearts, and of course, the patient that was on our panel or on our committee, to empower them to manage side effects and recognize when to seek help; and a stronger partnership with a care team, with regular follow-ups focused on their experience, challenges, and successes; and then, greater overall safety through proactive monitoring for medication errors or complications. So all of these aspects, or tenets, as I'll call them, are baked into these quality standards that are totally aligned with NCODA's core claims document that, again, talks about abandonment, adherence, access and affordability, speed to therapy, education, satisfaction for the patients, and also cost avoidance. Dr. Luis Raez: I only want to add and invite the community to adhere to these standards, to practice the standards. You will be providing the best patient care that we can nowadays. Brittany Harvey: Definitely. I think these standards are very important. And Michael, I thank you for touching on those key claims from NCODA. I think those, along with these updated standards, will improve outcomes for patients everywhere. So I want to thank you both so much for your work to update these standards and all the time you put into it. And thank you for your time today too, Michael and Dr. Raez. Michael Reff: I'd like to thank not only the committee, my esteemed committee that helped support the standards and the revision. Many of the original healthcare providers and patient that were on the first go of the standards were part of the second standards. We revised it, of course, and we got additional support from the new committee. And certainly ASCO and their partnership and collaboration with NCODA has been tremendous. And we look forward to the oncology community at large adopting these standards, again, to work together, we do become stronger, and it will improve cancer care for patients receiving oral anticancer medications. So thank you, Brittany. Dr. Luis Raez: I only want to say the same thing. Actually, there is probably more people in NCODA that is not in the publication that has helped. Same in ASCO. Also, we want to give thanks to Dr. Stephen Grubbs, our leader in quality. He's retiring. We're going to miss him, but he has been a key collaborator with Mike organizing these standards for the last five or six years. So, looking forward to these standards in practice. Brittany Harvey: Absolutely. A big thank you to the entire panel and everyone who contributed to this, and NCODA as well. And then finally, thank you to all of our listeners for tuning in to the ASCO Guidelines podcast. To read the complete standards, go to www.asco.org/standards. I also encourage you to check out the companion episode on these standards on the PQI podcast by NCODA, which you can find on Apple Podcasts and Spotify. You can also find many of our standards and interactive resources in the free ASCO Guidelines app, which is available in the Apple App Store or the Google Play Store. If you have enjoyed what you've heard today, please rate and review the podcast and be sure to subscribe so you never miss an episode.   The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.

In this follow-up to our last episode on MIPS (Merit-Based Incentive Payment System), Dr. Heather Signorelli takes a deeper dive into what physicians need to know to maximize Medicare reimbursements and avoid penalties. We unpack the four MIPS categories—Quality, Promoting Interoperability, Improvement Activities, and Cost—and how they impact your final score. You'll also hear real-world examples of specialty-specific metrics, tips for leveraging your EMR for MIPS success, and how group vs. individual reporting works. Whether you're new to MIPS or just looking to improve your performance, this episode is packed with actionable insights to help you stay compliant and boost revenue. 

Kevin M. Crawford, MD, FAAD interviewed by Mona Sadeghpour, MD, FAAD

In this episode, Cherise is joined by returning guest Vladimir Pajkic, Partner from ZGF Architects, a firm with multiple offices across North America and over 750 staff. They discuss the Jen-Hsun Huang and Lori Mills Huang Collaborative Innovation Complex (HCIC) at Oregon State University.You can see the project here as you listen along.At the north edge of Oregon State University's historic campus, a new landmark for innovation is taking shape. The Jen-Hsun Huang and Lori Mills Huang Collaborative Innovation Complex is a 143,000-square-foot facility designed to transform how OSU approaches science, research, and collaboration. The building is also making history as the first all-mass-timber experimental laboratory in the U.S. that meets a demanding 2000 MIPS vibration criterion.If you enjoy this episode, visit arcat.com/podcast for more. If you're a frequent listener of Detailed, you might enjoy similar content at Gābl Media. Mentioned in this episode:ARCATemy

Brandon and Dave talk through the latest news in the NBA during this episode of The NBA Hangout including:Raptors Tank jobAwards games limit ; Is it good ?West Contenders Teams not afraid of OKCPower ranking OKC, Denver, Warriors Memphis overlooked?Cleveland ready?Boston on track for a repeat?Eastern Conference dark horses (Bucks,Knicks & Pacers)MIP candidatesand much much more..Follow us on Twitter/X @TheNBAHangout for updates on the pod as well video highlights and moreFollow us on Twitter: @PlaybookSNFollow us on Instagram: @playbook.sports Hosted on Acast. See acast.com/privacy for more information.

Quels joueurs ont changé de dimension cette saison ? Avec @LesOUTSIDERZ , on s'est retrouvé pour dresser un top 5 de nos MIPs.

Are you ready to lead with clarity and purpose in 2025? Join me on Monday, December 30, at 3 PM ET for a FREE webinar: Take Control of Your Leadership: Clear Priorities, Real Results. In just one hour, you'll learn actionable strategies to define your priorities, recognize and reinforce values, and reclaim your time for the work that truly matters.Save your spot today at www.theprincipalacademy.com/realresults—let's kick off 2025 as your best leadership year yet!Are you feeling overwhelmed and struggling to prioritize your time as a school leader? In this episode, I share some exciting news about my upcoming digital course, Take Control of Your Leadership:. This course is designed to help you overcome overwhelm, focus on what truly matters, and lead with clarity, and it's LIVE - go to theprincipalacademy.com and check out Take Control of Your Leadership.In this engaging conversation, Dr. Darrin Peppard and Barbara Gruener explore the journey of entrepreneurship, the importance of relationships in education, and the therapeutic power of writing. Barbara shares her inspiring background, her transition back to teaching, and the significance of self-care for educators. They also discuss Barbara's latest book, Birdie and Mipps, which reflects on the themes of nicknames and relationships, and the feedback it has received from readers. The conversation concludes with Barbara's insights on leaning into leadership and supporting others in their journeys.TakeawaysEntrepreneurship can lead to meaningful connections.Teaching experiences shape our understanding of education.Relationships are at the core of effective teaching.Self-care is essential for educators to thrive.Writing serves as a therapeutic outlet for emotions.Birdie and Mips explores the significance of nicknames.Feedback from readers can highlight the impact of a book.Mentorship plays a crucial role in leadership.Inspiration and kindness can transform lives.Everyone is fighting their own battles, and empathy is key.Find Barbara at:corneroncharacter.combarbaragruenerauthor.com

  In this episode, we dive into the world of MIPS (Merit-Based Incentive Payment System) and its impact on healthcare providers. Hosted by Morgan Knight, Channel Manager for DrChrono by EverHealth, this conversation features Maura Flaherty, Partnership Sales Consultant, and Debbie Belczyk, Account Manager, from Healthmonix.  We explore the essentials of the MIPS program, its evolution, and the key challenges providers face. You'll hear insights on how Healthmonix's MIPS solutions seamlessly integrate with DrChrono's EHR platform and simplify the reporting process to improve practice financial outcomes. The discussion also touches on trends in value-based care, and upcoming changes in MIPS reporting – check out the webinar hosted by Healthmonix to learn more about the 2025 PFS Final Rule (*linked below).  Learn how the unique partnership between DrChrono and Healthmonix is empowering practices to comply with federal requirements, improve care quality, and maximize your practice's financial incentives. Whether you're new to MIPS or looking to optimize your reporting, this episode offers valuable takeaways for every provider.  Resources:  DrChrono by EverHealth Marketplace: MIPSPro  Quality Payment Program Website  Healthmonix Webinar: 2025 PFS Final Rule  2025 Medicare Physician Fee Schedule (PFS) Final Rule